OVERSEA CHINESE BANKING Corp Ltd Invests $323,000 in Aflac Incorporated (NYSE:AFL)

OVERSEA CHINESE BANKING Corp Ltd purchased a new position in shares of Aflac Incorporated (NYSE:AFL) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,120 shares of the financial services provider’s stock, valued at approximately $323,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Private Trust Co. NA boosted its position in shares of Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after buying an additional 99 shares during the period. Phillips Wealth Planners LLC boosted its position in shares of Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after buying an additional 100 shares during the period. Raleigh Capital Management Inc. boosted its position in shares of Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after buying an additional 100 shares during the period. TKG Advisors LLC boosted its position in shares of Aflac by 0.5% during the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after buying an additional 103 shares during the period. Finally, Robertson Stephens Wealth Management LLC boosted its holdings in Aflac by 1.6% in the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock valued at $720,000 after purchasing an additional 107 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Evercore ISI decreased their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. JPMorgan Chase & Co. lifted their target price on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Piper Sandler decreased their target price on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Barclays decreased their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Finally, Keefe, Bruyette & Woods decreased their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Aflac presently has a consensus rating of “Hold” and an average target price of $103.36.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now owns 25,393 shares in the company, valued at $2,733,048.59. The trade was a 3.79 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares in the company, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 55,546 shares of company stock worth $5,863,616 in the last quarter. Company insiders own 0.80% of the company’s stock.

Aflac Stock Up 0.2 %

AFL opened at $108.66 on Friday. The business’s 50-day simple moving average is $105.81 and its 200-day simple moving average is $107.66. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The stock has a market capitalization of $59.39 billion, a P/E ratio of 11.32, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.